LTFS
PETX

Ladenburg Thalmann Financial Services’s Aratana Therapeutics, Inc. PETX Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-8,380
Closed -$43K – 5646
2019
Q2 		$43K Hold
8,380
– – ﹤0.01% 3570
2019
Q1 		$30K Sell
8,380
-2
-0% -$9 ﹤0.01% 3765
2018
Q4 		$51K Buy
8,382
+2,002
+31% +$12.2K ﹤0.01% 3237
2018
Q3 		$37K Buy
6,380
+3,580
+128% +$17.9K ﹤0.01% 3525
2018
Q2 		$12K Hold
2,800
– – ﹤0.01% 4161
2018
Q1 		$12K Buy
2,800
+535
+24% +$2.39K ﹤0.01% 4161
2017
Q4 		$12K Hold
2,265
– – ﹤0.01% 4109
2017
Q3 		$14K Buy
2,265
+1,300
+135% +$8.23K ﹤0.01% 3915
2017
Q2 		$7K Hold
965
– – ﹤0.01% 4222
2017
Q1 		$5K Sell
965
-965
-50% -$6.52K ﹤0.01% 4343
2016
Q4 		$14K Hold
1,930
– – ﹤0.01% 3717
2016
Q3 		$18K Hold
1,930
– – ﹤0.01% 3482
2016
Q2 		$12K Hold
1,930
– – ﹤0.01% 3687
2016
Q1 		$11K Buy
1,930
+1,731
+870% +$6.51K ﹤0.01% 3672
2015
Q4 		$1K Hold
199
– – ﹤0.01% 4596
2015
Q3 		$2K Buy
+199
New +$3.37K ﹤0.01% 4323

Other funds holding PETX

DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Ladenburg Thalmann Financial Services's PETX Position: Q3 2019 in Review

Ladenburg Thalmann Financial Services sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 8,380 shares — an estimated $43K sold.

Ladenburg Thalmann Financial Services first reported a position in PETX in Q3 2015 and held it in 16 quarters. The position peaked at $51K in Q4 2018. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

  • Ladenburg Thalmann Financial Services reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 8,380 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $43K.
  • Ladenburg Thalmann Financial Services first reported a position in Aratana Therapeutics, Inc. in Q3 2015 and held it in 16 quarters.
  • Ladenburg Thalmann Financial Services's Aratana Therapeutics, Inc. position peaked at $51K in Q4 2018.
  • 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q3 2019, filed 14 Nov 2019.